Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Methodology|Interests|Funding|Corrections
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Bibliographic record

General Chapter ⟨921⟩ Water Determination

United States Pharmacopeial Convention. United States Pharmacopeia — National Formulary (USP–NF) 2024

Document identifier
CEI-BR-115
Series
Bibliographic record
Version
1.0
Published
30 Jul 2026
Last reviewed
30 Jul 2026
Certainty
Not rated

§1Bibliographic record

§1.1Record

Authors
United States Pharmacopeial Convention
Title
General Chapter ⟨921⟩ Water Determination
Source
United States Pharmacopeia — National Formulary (USP–NF)
Year
2024
Volume, issue, pages
USP 2024 Issue 1
Digital object identifier
not held by the Institute
PubMed identifier
not held by the Institute
Record type
Guideline
Institute identifier
CEI-BR-115

§1.2Institute documents citing this record

Table 1. Documents in the Institute set that cite this record.

DocumentSeries
Standard CEI-MS-04: Determination of water content in lyophilised peptides by coulometric…Methodological standard
1 citing document.

§1.3Subject tags

water karl-fischer method usp

Compound Evidence Institute · CEI-BR-115 · https://compoundevidence.com/bibliography/usp921/ · retrieved 30 July 2026
Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.